Required documentation includes: current BMI measurement (within 90 days), diagnosis code for obesity, documentation of 90 consecutive days of supervised lifestyle intervention with a qualified provider, attendance logs or food diaries proving adherence, documentation of step therapy completion or contraindication, and screening confirming no personal or family history of medullary thyroid carcinoma or MEN 2
Now, you might not have read about this weight loss injection yet, and thats because its still being developed by US pharmaceutical giant and the inventor, Eli Lilly
Semaglutide is a GLP-1 receptor agonist, a peptide-based medication
Because Wegovy contains semaglutide, it should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
This can help manage collective side effects, including acid reflux, abdominal distension, and bloating